 |
|
JAMA-EXPRESS
Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy
The Women's Health Initiative Randomized Controlled Trial
The Women's Health Initiative Steering Committee*
JAMA. 2004;291:1701-1712.
Context Despite decades of use and considerable research, the role of estrogen alone in preventing chronic diseases in postmenopausal women remains uncertain.
Objective To assess the effects on major disease incidence rates of the most commonly used postmenopausal hormone therapy in the United States.
Design, Setting, and Participants A randomized, double-blind, placebo-controlled disease prevention trial (the estrogen-alone component of the Women's Health Initiative [WHI]) conducted in 40 US clinical centers beginning in 1993. Enrolled were 10 739 postmenopausal women, aged 50-79 years, with prior hysterectomy, including 23% of minority race/ethnicity.
Intervention Women were randomly assigned to receive either 0.625 mg/d of conjugated equine estrogen (CEE) or placebo.
Main Outcome Measures The primary outcome was coronary heart disease (CHD) incidence (nonfatal myocardial infarction or CHD death). Invasive breast cancer incidence was the primary safety outcome. A global index of risks and benefits, including these primary outcomes plus stroke, pulmonary embolism (PE), colorectal cancer, hip fracture, and deaths from other causes, was used for summarizing overall effects.
Results In February 2004, after reviewing data through November 30, 2003, the National Institutes of Health (NIH) decided to end the intervention phase of the trial early. Estimated hazard ratios (HRs) (95% confidence intervals [CIs]) for CEE vs placebo for the major clinical outcomes available through February 29, 2004 (average follow-up 6.8 years), were: CHD, 0.91 (0.75-1.12) with 376 cases; breast cancer, 0.77 (0.59-1.01) with 218 cases; stroke, 1.39 (1.10-1.77) with 276 cases; PE, 1.34 (0.87-2.06) with 85 cases; colorectal cancer, 1.08 (0.75-1.55) with 119 cases; and hip fracture, 0.61 (0.41-0.91) with 102 cases. Corresponding results for composite outcomes were: total cardiovascular disease, 1.12 (1.01-1.24); total cancer, 0.93 (0.81-1.07); total fractures, 0.70 (0.63-0.79); total mortality, 1.04 (0.88-1.22), and the global index, 1.01 (0.91-1.12). For the outcomes significantly affected by CEE, there was an absolute excess risk of 12 additional strokes per 10 000 person-years and an absolute risk reduction of 6 fewer hip fractures per 10 000 person-years. The estimated excess risk for all monitored events in the global index was a nonsignificant 2 events per 10 000 person-years.
Conclusions The use of CEE increases the risk of stroke, decreases the risk of hip fracture, and does not affect CHD incidence in postmenopausal women with prior hysterectomy over an average of 6.8 years. A possible reduction in breast cancer risk requires further investigation. The burden of incident disease events was equivalent in the CEE and placebo groups, indicating no overall benefit. Thus, CEE should not be recommended for chronic disease prevention in postmenopausal women.
*Authors/WHI Steering Committee: Garnet L. Anderson, PhD (writing group chair, Fred Hutchinson Cancer Research Center, Seattle, Wash); Marian Limacher, MD (writing group cochair, University of Florida, Gainesville/Jacksonville). Members (in alphabetical order): Annlouise R. Assaf, PhD (Brown University, Providence, RI); Tamsen Bassford, MD (University of Arizona, Tucson/Phoenix); Shirley A. A. Beresford, PhD (Fred Hutchinson Cancer Research Center, Seattle); Henry Black, MD (Rush-Presbyterian-St Luke's Medical Center, Chicago, Ill); Denise Bonds, MD (Wake Forest University School of Medicine, Winston-Salem, NC); Robert Brunner, PhD (University of Nevada, Reno); Robert Brzyski, MD (University of Texas Health Science Center, San Antonio); Bette Caan, DrPH (Kaiser Permanente Division of Research, Oakland, Calif); Rowan Chlebowski, MD (Harbor-UCLA Research and Education Institute, Torrance, Calif); David Curb, MD (University of Hawaii, Honolulu); Margery Gass, MD (University of Cincinnati, Cincinnati, Ohio); Jennifer Hays, PhD (Baylor College of Medicine, Houston, Tex); Gerardo Heiss, MD (University of North Carolina, Chapel Hill); Susan Hendrix, DO (Wayne State University School of Medicine/Hutzel Hospital, Detroit, Mich); Barbara V. Howard, PhD (MedStar Research Institute/Howard University, Washington, DC); Judith Hsia, MD (George Washington University Medical Center, Washington, DC); Allan Hubbell, MD (University of California at Irvine, Orange); Rebecca Jackson, MD (The Ohio State University, Columbus); Karen C. Johnson, MD (University of Tennessee, Memphis); Howard Judd, MD (University of California at Los Angeles); Jane Morley Kotchen, MD (Medical College of Wisconsin, Milwaukee); Lewis Kuller, MD (University of Pittsburgh, Pittsburgh, Pa); Andrea Z. LaCroix, PhD (Fred Hutchinson Cancer Research Center, Seattle); Dorothy Lane, MD (State University of New York at Stony Brook); Robert D. Langer, MD (University of California at San Diego, LaJolla/Chula Vista); Norman Lasser, MD (University of Medicine and Dentistry of New Jersey, Newark); Cora E. Lewis, MD (University of Alabama at Birmingham); JoAnn Manson, MD (Brigham and Women's Hospital, Harvard Medical School, Boston, Mass); Karen Margolis, MD (University of Minnesota, Minneapolis); Judith Ockene, PhD (University of Massachusetts/Fallon Clinic, Worcester); Mary Jo O'Sullivan, MD (University of Miami, Miami, Fla); Lawrence Phillips, MD (Emory University, Atlanta, Ga); Ross L. Prentice, PhD (Fred Hutchinson Cancer Research Center, Seattle); Cheryl Ritenbaugh, PhD (Kaiser Permanente Center for Health Research, Portland, Ore); John Robbins, MD (University of California at Davis, Sacramento); Jacques E. Rossouw, MD (National Heart, Lung, and Blood Institute, Bethesda, Md); Gloria Sarto, MD (University of Wisconsin, Madison); Marcia L. Stefanick, PhD (Stanford Prevention Research Center, Stanford University, Stanford, Calif); Linda Van Horn, PhD (Northwestern University, Chicago, Ill); Jean Wactawski-Wende, PhD (University at Buffalo, Buffalo, NY); Robert Wallace, MD (University of Iowa, Iowa City/Davenport); Sylvia Wassertheil-Smoller, PhD (Albert Einstein College of Medicine, Bronx, NY).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Effects of Estrogen-Only Treatment in Postmenopausal Women
Herbert Kuhl
JAMA. 2004;292(6):683.
EXTRACT
| FULL TEXT
Effects of Estrogen-Only Treatment in Postmenopausal Women
Matti A. Rookus and Flora E. van Leeuwen
JAMA. 2004;292(6):683.
EXTRACT
| FULL TEXT
Effects of Estrogen-Only Treatment in Postmenopausal Women
Vicki F. Meyer
JAMA. 2004;292(6):683-684.
EXTRACT
| FULL TEXT
Effects of Estrogen-Only Treatment in Postmenopausal Women
Valerie Beral, Emily Banks, and Gillian Reeves
JAMA. 2004;292(6):684.
EXTRACT
| FULL TEXT
Effects of Estrogen-Only Treatment in Postmenopausal Women
Carlo Campagnoli, Chiara Abbà, Simona Ambroggio, and Clementina Peris
JAMA. 2004;292(6):684.
EXTRACT
| FULL TEXT
Effects of Estrogen-Only Treatment in Postmenopausal Women
Karla Kerlikowske and Diana L. Miglioretti
JAMA. 2004;292(6):684-685.
EXTRACT
| FULL TEXT
Effects of Estrogen-Only Treatment in Postmenopausal Women
Frank A. Perlroth
JAMA. 2004;292(6):685.
EXTRACT
| FULL TEXT
Effects of Estrogen-Only Treatment in Postmenopausal Women
Michael H. Cooper
JAMA. 2004;292(6):685.
EXTRACT
| FULL TEXT
Effects of Estrogen-Only Treatment in Postmenopausal Women—Reply
Stephen B. Hulley and Deborah Grady
JAMA. 2004;292(6):686-687.
EXTRACT
| FULL TEXT
Hormone Therapy and Cardiovascular Risk
Lynn E. T. Shaffer and Carl A. Krantz
JAMA. 2007;298(6):623-624.
EXTRACT
| FULL TEXT
RELATED ARTICLES
The WHI Estrogen-Alone Trial—Do Things Look Any Better?
Stephen B. Hulley and Deborah Grady
JAMA. 2004;291(14):1769-1771.
EXTRACT
| FULL TEXT
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density: The Women's Health Initiative Randomized Trial
Jane A. Cauley, John Robbins, Zhao Chen, Steven R. Cummings, Rebecca D. Jackson, Andrea Z. LaCroix, Meryl LeBoff, Cora E. Lewis, Joan McGowan, Joan Neuner, Mary Pettinger, Marcia L. Stefanick, Jean Wactawski-Wende, and Nelson B. Watts
JAMA. 2003;290(13):1729-1738.
ABSTRACT
| FULL TEXT
Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial
Rowan T. Chlebowski, Susan L. Hendrix, Robert D. Langer, Marcia L. Stefanick, Margery Gass, Dorothy Lane, Rebecca J. Rodabough, Mary Ann Gilligan, Michele G. Cyr, Cynthia A. Thomson, Janardan Khandekar, Helen Petrovitch, and Anne McTiernan
JAMA. 2003;289(24):3243-3253.
ABSTRACT
| FULL TEXT
Relationship Between Long Durations and Different Regimens of Hormone Therapy and Risk of Breast Cancer
Christopher I. Li, Kathleen E. Malone, Peggy L. Porter, Noel S. Weiss, Mei-Tzu C. Tang, Kara L. Cushing-Haugen, and Janet R. Daling
JAMA. 2003;289(24):3254-3263.
ABSTRACT
| FULL TEXT
Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women: The Women's Health Initiative: A Randomized Trial
Sylvia Wassertheil-Smoller, Susan Hendrix, Marian Limacher, Gerardo Heiss, Charles Kooperberg, Alison Baird, Theodore Kotchen, J. David Curb, Henry Black, Jacques E. Rossouw, Aaron Aragaki, Monika Safford, Evan Stein, Somchai Laowattana, and W. Jerry Mysiw
JAMA. 2003;289(20):2673-2684.
ABSTRACT
| FULL TEXT
Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women: A Randomized Controlled Trial
David D. Waters, Edwin L. Alderman, Judith Hsia, Barbara V. Howard, Frederick R. Cobb, William J. Rogers, Pamela Ouyang, Paul Thompson, Jean Claude Tardif, Lyall Higginson, Vera Bittner, Michael Steffes, David J. Gordon, Michael Proschan, Naji Younes, and Joel I. Verter
JAMA. 2002;288(19):2432-2440.
ABSTRACT
| FULL TEXT
Postmenopausal Hormone Replacement Therapy: Scientific Review
Heidi D. Nelson, Linda L. Humphrey, Peggy Nygren, Steven M. Teutsch, and Janet D. Allan
JAMA. 2002;288(7):872-881.
ABSTRACT
| FULL TEXT
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)
Deborah Grady, David Herrington, Vera Bittner, Roger Blumenthal, Michael Davidson, Mark Hlatky, Judith Hsia, Stephen Hulley, Alan Herd, Steven Khan, L. Kristin Newby, David Waters, Eric Vittinghoff, Nanette Wenger, and for the HERS Research Group
JAMA. 2002;288(1):49-57.
ABSTRACT
| FULL TEXT
Hormone Replacement Therapy and Prevention of Nonvertebral Fractures: A Meta-analysis of Randomized Trials
David J. Torgerson and Sally E. M. Bell-Syer
JAMA. 2001;285(22):2891-2897.
ABSTRACT
| FULL TEXT
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Stephen Hulley, Deborah Grady, Trudy Bush, Curt Furberg, David Herrington, Betty Riggs, Eric Vittinghoff, and for the Heart and Estrogen/progestin Replacement Study Research Group
JAMA. 1998;280(7):605-613.
ABSTRACT
| FULL TEXT
Venous Thromboembolic Events Associated With Hormone Replacement Therapy
Deborah Grady, Stephen B. Hulley, and Curt Furberg
JAMA. 1997;278(6):477.
PDF
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Brain Volumes, Cognitive Impairment, and Conjugated Equine Estrogens
Espeland et al.
J Gerontol A Biol Sci Med Sci 2009;64A:1243-1250.
ABSTRACT
| FULL TEXT
Genetic Variation in the Progesterone Receptor and Metabolism Pathways and Hormone Therapy in Relation to Breast Cancer Risk
Reding et al.
Am J Epidemiol 2009;170:1241-1249.
ABSTRACT
| FULL TEXT
Estrogen Attenuates Ischemic Oxidative Damage via an Estrogen Receptor {alpha}-Mediated Inhibition of NADPH Oxidase Activation
Zhang et al.
J. Neurosci. 2009;29:13823-13836.
ABSTRACT
| FULL TEXT
Effects of Conjugated Equine Estrogens on Cognition and Affect in Postmenopausal Women with Prior Hysterectomy
Resnick et al.
J. Clin. Endocrinol. Metab. 2009;94:4152-4161.
ABSTRACT
| FULL TEXT
Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats
Deschamps and Murphy
Am. J. Physiol. Heart Circ. Physiol. 2009;297:H1806-H1813.
ABSTRACT
| FULL TEXT
Mammographic Screening and Risk Factors for Breast Cancer
Cook et al.
Am J Epidemiol 2009;0:kwp304v1-kwp304.
ABSTRACT
| FULL TEXT
Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis
Huber et al.
Hum Reprod Update 2009;0:dmp040v1-dmp040.
FULL TEXT
Estrogen Decreases Atherosclerosis in Part by Reducing Hepatic Acyl-CoA:Cholesterol Acyltransferase 2 (ACAT2) in Monkeys
Kavanagh et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:1471-1477.
ABSTRACT
| FULL TEXT
Should the ovaries be removed or retained at the time of hysterectomy for benign disease?
Hickey et al.
Hum Reprod Update 2009;0:dmp037v1-dmp037.
ABSTRACT
| FULL TEXT
The Relationship Between Cognitive Function and Physical Performance in Older Women: Results From the Women's Health Initiative Memory Study
Atkinson et al.
J Gerontol A Biol Sci Med Sci 2009;0:glp149v1-glp149.
ABSTRACT
| FULL TEXT
Cardiovascular Effects of Noncardiovascular Drugs
Raj et al.
Circulation 2009;120:1123-1132.
FULL TEXT
Use of Hormone Replacement Therapy and the Risk of Colorectal Cancer
Rennert et al.
JCO 2009;27:4542-4547.
ABSTRACT
| FULL TEXT
"Timing Hypothesis" for Hormone Therapy: Still Viable, or Time to Let Go?
JWatch General 2009;2009:1-1.
FULL TEXT
Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer
Nelson et al.
ANN INTERN MED 2009;0:0000605-200911170-00147v1-E-147.
ABSTRACT
| FULL TEXT
Efficacy, Safety, and Tolerability of Low-Dose Hormone Therapy in Managing Menopausal Symptoms
Langer
J Am Board Fam Med 2009;22:563-573.
ABSTRACT
| FULL TEXT
Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
Hembree et al.
J. Clin. Endocrinol. Metab. 2009;94:3132-3154.
ABSTRACT
| FULL TEXT
Effects of Oral Estrogen on Aortic ROS-Generating and -Scavenging Enzymes and Atherosclerosis in apoE-Deficient Mice
Wing et al.
Exp. Biol. Med. 2009;234:1037-1046.
ABSTRACT
| FULL TEXT
Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor-Positive, Aromatase Inhibitor-Resistant Advanced Breast Cancer: A Phase 2 Randomized Study
Ellis et al.
JAMA 2009;302:774-780.
ABSTRACT
| FULL TEXT
Trends and determinants of prescription medication use for treatment of osteoporosis
Farley and Blalock
Am J Health Syst Pharm 2009;66:1191-1201.
ABSTRACT
| FULL TEXT
Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17{beta}-estradiol and norethisterone when compared with an orally administered 17{beta}-estradiol norethisterone regimen
Rozenberg et al.
Hum Reprod 2009;24:1739-1747.
ABSTRACT
| FULL TEXT
Invited Commentary: Hormone Therapy Risks and Benefits--The Women's Health Initiative Findings and the Postmenopausal Estrogen Timing Hypothesis
Banks and Canfell
Am J Epidemiol 2009;170:24-28.
ABSTRACT
| FULL TEXT
Benefits and Risks of Postmenopausal Hormone Therapy When It Is Initiated Soon After Menopause
Prentice et al.
Am J Epidemiol 2009;170:12-23.
ABSTRACT
| FULL TEXT
Cancer Prevention: From 1727 to Milestones of the Past 100 Years
Lippman and Hawk
Cancer Res. 2009;69:5269-5284.
ABSTRACT
| FULL TEXT
Postmenopausal Hormone Treatment
Hulley and Grady
JAMA 2009;301:2493-2495.
FULL TEXT
Why are physicians reluctant to use estrogens for anything - or do they prefer 'PROFOX'?
Studd
Menopause Int 2009;15:52-54.
ABSTRACT
| FULL TEXT
Hormone replacement therapy and cardiovascular disease revisited
Stevenson
Menopause Int 2009;15:55-57.
ABSTRACT
| FULL TEXT
Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: the Women's Health Initiative Dietary Modification Trial
McTiernan et al.
Am. J. Clin. Nutr. 2009;89:1864-1876.
ABSTRACT
| FULL TEXT
Colorectal Cancer in Relation to Postmenopausal Estrogen and Estrogen Plus Progestin in the Women's Health Initiative Clinical Trial and Observational Study
Prentice et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:1531-1537.
ABSTRACT
| FULL TEXT
Breast cancer in young women and its impact on reproductive function
Hickey et al.
Hum Reprod Update 2009;15:323-339.
ABSTRACT
| FULL TEXT
Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone
Fanciulli et al.
Hum Reprod Update 2009;15:341-358.
ABSTRACT
| FULL TEXT
Perspectives on the soy-breast cancer relation
Messina and Wu
Am. J. Clin. Nutr. 2009;89:1673S-1679S.
ABSTRACT
| FULL TEXT
Sex Differences in Caspase Activation After Stroke
Liu et al.
Stroke 2009;40:1842-1848.
ABSTRACT
| FULL TEXT
Cardiovascular Effects of Physiological and Standard Sex Steroid Replacement Regimens in Premature Ovarian Failure
Langrish et al.
Hypertension 2009;53:805-811.
ABSTRACT
| FULL TEXT
Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis
Doren
Eur Heart J 2009;30:866-867.
FULL TEXT
Interference of Progestins With Endothelial Actions of Estrogens: A Matter of Glucocorticoid Action or Deprivation?
Arnal et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:441-443.
FULL TEXT
Stroke in Women: An Evolving Topic
Kurth and Bousser
Stroke 2009;40:1027-1028.
FULL TEXT
Age at Natural Menopause and Risk of Ischemic Stroke: The Framingham Heart Study
Lisabeth et al.
Stroke 2009;40:1044-1049.
ABSTRACT
| FULL TEXT
Cost-effectiveness of hormone replacement therapy for menopausal symptoms in the UK
Lekander et al.
Menopause Int 2009;15:19-25.
ABSTRACT
| FULL TEXT
Prevention, Diagnosis, and Management of Osteoporosis-Related Fracture
Fakih
JAOA: Journal of the American Osteopathic Association 2009;109:191-193.
FULL TEXT
Estrogen and Mechanisms of Vascular Protection
Xing et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:289-295.
ABSTRACT
| FULL TEXT
Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors
Collins et al.
Circulation 2009;119:922-930.
ABSTRACT
| FULL TEXT
Statistical methods in pharmacoepidemiology: advances and challenges
Suissa
Stat Methods Med Res 2009;18:3-6.
New Therapies for Osteoporosis
Hegge et al.
Journal of Pharmacy Practice 2009;22:53-64.
ABSTRACT
Steroid Sulfatase and Estrogen Sulfotransferase in Colon Carcinoma: Regulators of Intratumoral Estrogen Concentrations and Potent Prognostic Factors
Sato et al.
Cancer Res. 2009;69:914-922.
ABSTRACT
| FULL TEXT
Limited evidence for a protective effect of unopposed oestrogen therapy for osteoarthritis of the hip: a systematic review
de Klerk et al.
Rheumatology (Oxford) 2009;48:104-112.
ABSTRACT
| FULL TEXT
Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings
Tannen et al.
BMJ 2009;338:b81-b81.
ABSTRACT
| FULL TEXT
Contraceptive hormone use and cardiovascular disease.
Shufelt and Bairey Merz
J Am Coll Cardiol 2009;53:221-231.
ABSTRACT
| FULL TEXT
Postmenopausal hormone therapy and subclinical cerebrovascular disease: The WHIMS-MRI Study
Coker et al.
Neurology 2009;72:125-134.
ABSTRACT
| FULL TEXT
Postmenopausal hormone therapy and regional brain volumes: The WHIMS-MRI Study
Resnick et al.
Neurology 2009;72:135-142.
ABSTRACT
| FULL TEXT
The Potential for Estrogens in Preventing Alzheimer's Disease.
Simpkins et al.
Therapeutic Advances in Neurological Disorders 2009;2:31-49.
ABSTRACT
Menopausal Hormone Therapy and Risk of Colorectal Cancer
Johnson et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:196-203.
ABSTRACT
| FULL TEXT
Postmenopausal Levels of Endogenous Sex Hormones and Risk of Colorectal Cancer
Clendenen et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:275-281.
ABSTRACT
| FULL TEXT
Reassessing Benefits and Risks of Hormone Therapy
Gass et al.
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2009;3:29-43.
ABSTRACT
Differential Biochemical and Cellular Actions of Premarin Estrogens: Distinct Pharmacology of Bazedoxifene-Conjugated Estrogens Combination
Berrodin et al.
Mol. Endocrinol. 2009;23:74-85.
ABSTRACT
| FULL TEXT
Update on JAMA-EXPRESS: Rapid Review and Publication
Fontanarosa and DeAngelis
JAMA 2008;300:2920-2921.
FULL TEXT
Approach to the Patient with Menopausal Symptoms
Martin and Manson
J. Clin. Endocrinol. Metab. 2008;93:4567-4575.
ABSTRACT
| FULL TEXT
The Pairing of a Selective Estrogen Receptor Modulator, Bazedoxifene, with Conjugated Estrogens as a New Paradigm for the Treatment of Menopausal Symptoms and Osteoporosis Prevention
Kharode et al.
Endocrinology 2008;149:6084-6091.
ABSTRACT
| FULL TEXT
Calcium Plus Vitamin D Supplementation and the Risk of Breast Cancer
Chlebowski et al.
JNCI J Natl Cancer Inst 2008;100:1581-1591.
ABSTRACT
| FULL TEXT
Inflammatory, Lipid, Thrombotic, and Genetic Markers of Coronary Heart Disease Risk in the Women's Health Initiative Trials of Hormone Therapy
Rossouw et al.
Arch Intern Med 2008;168:2245-2253.
ABSTRACT
| FULL TEXT
Opportunities and Strategies for Breast Cancer Prevention Through Risk Reduction
Mahoney et al.
CA Cancer J Clin 2008;0:CA.2008.0016v1-CA.2008.0016.
ABSTRACT
| FULL TEXT
Menopausal Hormone Therapy and Breast Cancer Risk in the NIH-AARP Diet and Health Study Cohort
Brinton et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:3150-3160.
ABSTRACT
| FULL TEXT
Hormone therapy and risk of myocardial infarction: a national register study
Lokkegaard et al.
Eur Heart J 2008;29:2660-2668.
ABSTRACT
| FULL TEXT
Osteoporosis Primer for the Vertebroplasty Practitioner: Expanding the Focus Beyond Needles and Cement
Kearns and Kallmes
Am. J. Neuroradiol. 2008;29:1816-1822.
ABSTRACT
| FULL TEXT
Prevention, Diagnosis, and Management of Osteoporosis-Related Fracture: A Multifactoral Osteopathic Approach
Gronholz
JAOA: Journal of the American Osteopathic Association 2008;108:575-585.
ABSTRACT
| FULL TEXT
Conjugated Equine Estrogens and Colorectal Cancer Incidence and Survival: The Women's Health Initiative Randomized Clinical Trial
Ritenbaugh et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2609-2618.
ABSTRACT
| FULL TEXT
Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
Eisen et al.
JNCI J Natl Cancer Inst 2008;100:1361-1367.
ABSTRACT
| FULL TEXT
Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer
Hickey et al.
Ann Oncol 2008;19:1669-1680.
ABSTRACT
| FULL TEXT
Pharmacologic Treatment of Low Bone Density or Osteoporosis to Prevent Fractures: A Clinical Practice Guideline from the American College of Physicians
Qaseem et al.
ANN INTERN MED 2008;149:404-415.
ABSTRACT
| FULL TEXT
Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones
Mueller and Gooren
Eur J Endocrinol 2008;159:197-202.
ABSTRACT
| FULL TEXT
Estrogen plus Progestin and Risk of Benign Proliferative Breast Disease
Rohan et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2337-2343.
ABSTRACT
| FULL TEXT
Seladin-1 Is a Fundamental Mediator of the Neuroprotective Effects of Estrogen in Human Neuroblast Long-Term Cell Cultures
Luciani et al.
Endocrinology 2008;149:4256-4266.
ABSTRACT
| FULL TEXT
Lipoprotein Particle Concentrations May Explain the Absence of Coronary Protection in the Women's Health Initiative Hormone Trials
Hsia et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:1666-1671.
ABSTRACT
| FULL TEXT
Cancer and cholesterol: understanding the V-shaped association in patients with diabetes
Ding and Hu
CMAJ 2008;179:403-404.
FULL TEXT
Epidemiology of Cytokines: The Women On the Move through Activity and Nutrition (WOMAN) Study
Wong et al.
Am J Epidemiol 2008;168:443-453.
ABSTRACT
| FULL TEXT
The Effects of Tibolone in Older Postmenopausal Women
Cummings et al.
NEJM 2008;359:697-708.
ABSTRACT
| FULL TEXT
Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis
Sare et al.
Eur Heart J 2008;29:2031-2041.
ABSTRACT
| FULL TEXT
Synergism between Oral Estrogen Therapy and Cytochrome P450 3A5*1 Allele on the Risk of Venous Thromboembolism among Postmenopausal Women
Canonico et al.
J. Clin. Endocrinol. Metab. 2008;93:3082-3087.
ABSTRACT
| FULL TEXT
Comparative Analysis of the Uterine and Mammary Gland Effects of Drospirenone and Medroxyprogesterone Acetate
Otto et al.
Endocrinology 2008;149:3952-3959.
ABSTRACT
| FULL TEXT
Oestrogen plays a permissive role in cardioprotection
Cohen and Downey
Cardiovasc Res 2008;79:353-354.
FULL TEXT
Update on Hormone Therapy: Evidence-Based Approaches
JWatch Women's Health 2008;2008:1-1.
FULL TEXT
Low-Fat Dietary Pattern and Risk of Treated Diabetes Mellitus in Postmenopausal Women: The Women's Health Initiative Randomized Controlled Dietary Modification Trial
Tinker et al.
Arch Intern Med 2008;168:1500-1511.
ABSTRACT
| FULL TEXT
|
